Afrezza: Will it revolutionize insulin therapy?
The FDA approved the inhaled insulin, Afrezza, last summer, and it will likely undergo a massive marketing campaign to providers and possibly to people with diabetes directly. Here is some important clinical trial information about the medicine and how it is indicated for use in patients.